Myricetin ameliorates atherosclerosis in the low-density-lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cells

Abstract Background Myricetin, a major flavonoid found in several foods including berries, grapes and wine, exhibited strong antioxidant potency, yet the effect on atherosclerosis is not fully understood. In this study, we examined the effect of myricetin on lipid accumulation in macrophage and athe...

Full description

Bibliographic Details
Main Authors: Zhe Meng, Mengyu Wang, Junhui Xing, Yuzhou Liu, Haiyu Li
Format: Article
Language:English
Published: BMC 2019-04-01
Series:Nutrition & Metabolism
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12986-019-0354-7
_version_ 1818148435092570112
author Zhe Meng
Mengyu Wang
Junhui Xing
Yuzhou Liu
Haiyu Li
author_facet Zhe Meng
Mengyu Wang
Junhui Xing
Yuzhou Liu
Haiyu Li
author_sort Zhe Meng
collection DOAJ
description Abstract Background Myricetin, a major flavonoid found in several foods including berries, grapes and wine, exhibited strong antioxidant potency, yet the effect on atherosclerosis is not fully understood. In this study, we examined the effect of myricetin on lipid accumulation in macrophage and atherosclerosis in atherosclerosis-prone low density lipoprotein receptor-deficient (Ldlr −/− ) mice. Methods Ldlr −/− mice were fed an atherogenic diet supplemented with myricetin (0.15% in the diet, v/v) for 8 weeks. Body weight, adipose tissue weight, food intake, serum biochemical parameters were measured. Atherosclerosis lesions and macrophages accumulaton in lesions were analyzed and quantified. Macrophages were exposed to 20 μM of myricetin before incubated with oxidized low-density lipoprotein (ox-LDL) (25μg/mL) or Dil-ox-LDL for the indicated time. Lipid uptake and foam cell formation were evaluated by flow cytometry and microscopy. The intracellular lipids were extracted and measured. mRNA expression and protein of cholesterol metabolism related receptors were analyzed. Results Myricetin administration reduced the weight, plasma lipid levels but not food intake in Ldlr −/− mice when fed an atherogenic diet. Myceritin-treated Ldlr −/− mice displayed significantly less atherosclerotic areas and macrophages in the cross sections of the aortic root. There were also less lipophilic areas in En face Oil red O staining of aorta from myceritin-treated Ldlr −/− mice. Myceritin treatment also markedly ameliorated ox-LDL-induced cholesterol accumulation in macrophages. The expression of CD36 were decreased in myricetin treated macrophages with ox-LDL incubation, while scavenger receptors class A (SR-A) and scavenger receptors class B (SR-BI) expression was not altered, indicating that these effect of myricetin were dependent on CD36 pathway. Conclusions Our findings indicated that myricetin suppressed cholesterol accumulation in macrophage foam cells by inhibition of CD36-mediated ox-LDL uptake, and suggested myricetin may have an important therapeutic function for atherosclerosis.
first_indexed 2024-12-11T12:51:05Z
format Article
id doaj.art-3ef46ca6fb094a1b939446c890d40619
institution Directory Open Access Journal
issn 1743-7075
language English
last_indexed 2024-12-11T12:51:05Z
publishDate 2019-04-01
publisher BMC
record_format Article
series Nutrition & Metabolism
spelling doaj.art-3ef46ca6fb094a1b939446c890d406192022-12-22T01:06:41ZengBMCNutrition & Metabolism1743-70752019-04-011611910.1186/s12986-019-0354-7Myricetin ameliorates atherosclerosis in the low-density-lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cellsZhe Meng0Mengyu Wang1Junhui Xing2Yuzhou Liu3Haiyu Li4Department of Cardiology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Cardiology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Cardiology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Cardiology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Cardiology, The First Affiliated Hospital of Zhengzhou UniversityAbstract Background Myricetin, a major flavonoid found in several foods including berries, grapes and wine, exhibited strong antioxidant potency, yet the effect on atherosclerosis is not fully understood. In this study, we examined the effect of myricetin on lipid accumulation in macrophage and atherosclerosis in atherosclerosis-prone low density lipoprotein receptor-deficient (Ldlr −/− ) mice. Methods Ldlr −/− mice were fed an atherogenic diet supplemented with myricetin (0.15% in the diet, v/v) for 8 weeks. Body weight, adipose tissue weight, food intake, serum biochemical parameters were measured. Atherosclerosis lesions and macrophages accumulaton in lesions were analyzed and quantified. Macrophages were exposed to 20 μM of myricetin before incubated with oxidized low-density lipoprotein (ox-LDL) (25μg/mL) or Dil-ox-LDL for the indicated time. Lipid uptake and foam cell formation were evaluated by flow cytometry and microscopy. The intracellular lipids were extracted and measured. mRNA expression and protein of cholesterol metabolism related receptors were analyzed. Results Myricetin administration reduced the weight, plasma lipid levels but not food intake in Ldlr −/− mice when fed an atherogenic diet. Myceritin-treated Ldlr −/− mice displayed significantly less atherosclerotic areas and macrophages in the cross sections of the aortic root. There were also less lipophilic areas in En face Oil red O staining of aorta from myceritin-treated Ldlr −/− mice. Myceritin treatment also markedly ameliorated ox-LDL-induced cholesterol accumulation in macrophages. The expression of CD36 were decreased in myricetin treated macrophages with ox-LDL incubation, while scavenger receptors class A (SR-A) and scavenger receptors class B (SR-BI) expression was not altered, indicating that these effect of myricetin were dependent on CD36 pathway. Conclusions Our findings indicated that myricetin suppressed cholesterol accumulation in macrophage foam cells by inhibition of CD36-mediated ox-LDL uptake, and suggested myricetin may have an important therapeutic function for atherosclerosis.http://link.springer.com/article/10.1186/s12986-019-0354-7MyricetinMacrophageAtherosclerosisCD36
spellingShingle Zhe Meng
Mengyu Wang
Junhui Xing
Yuzhou Liu
Haiyu Li
Myricetin ameliorates atherosclerosis in the low-density-lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cells
Nutrition & Metabolism
Myricetin
Macrophage
Atherosclerosis
CD36
title Myricetin ameliorates atherosclerosis in the low-density-lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cells
title_full Myricetin ameliorates atherosclerosis in the low-density-lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cells
title_fullStr Myricetin ameliorates atherosclerosis in the low-density-lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cells
title_full_unstemmed Myricetin ameliorates atherosclerosis in the low-density-lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cells
title_short Myricetin ameliorates atherosclerosis in the low-density-lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cells
title_sort myricetin ameliorates atherosclerosis in the low density lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cells
topic Myricetin
Macrophage
Atherosclerosis
CD36
url http://link.springer.com/article/10.1186/s12986-019-0354-7
work_keys_str_mv AT zhemeng myricetinamelioratesatherosclerosisinthelowdensitylipoproteinreceptorknockoutmicebysuppressionofcholesterolaccumulationinmacrophagefoamcells
AT mengyuwang myricetinamelioratesatherosclerosisinthelowdensitylipoproteinreceptorknockoutmicebysuppressionofcholesterolaccumulationinmacrophagefoamcells
AT junhuixing myricetinamelioratesatherosclerosisinthelowdensitylipoproteinreceptorknockoutmicebysuppressionofcholesterolaccumulationinmacrophagefoamcells
AT yuzhouliu myricetinamelioratesatherosclerosisinthelowdensitylipoproteinreceptorknockoutmicebysuppressionofcholesterolaccumulationinmacrophagefoamcells
AT haiyuli myricetinamelioratesatherosclerosisinthelowdensitylipoproteinreceptorknockoutmicebysuppressionofcholesterolaccumulationinmacrophagefoamcells